Suven Life Sciences jumps higher on the BSE

28 Dec 2018 Evaluate

Suven Life Sciences is currently trading at Rs. 230.95, up by 4.80 points or 2.12% from its previous closing of Rs. 226.15 on the BSE.

The scrip opened at Rs. 227.75 and has touched a high and low of Rs. 233.30 and Rs. 227.60 respectively. So far 41031 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 337.70 on 11-Sep-2018 and a 52 week low of Rs. 163.30 on 23-Mar-2018.

Last one week high and low of the scrip stood at Rs. 233.30 and Rs. 216.90 respectively. The current market cap of the company is Rs. 2940.23 crore.

The promoters holding in the company stood at 60.00%, while Institutions and Non-Institutions held 7.91% and 32.09% respectively.

Suven Life Sciences (Suven) has secured one product patent from Brazil and one product patent from Eurasia corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2023 and 2034 respectively.

The granted claims of the patents include the class of selective 5-HT6 and 5-HT4 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia etc.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Suven Life Sciences Share Price

118.15 -2.65 (-2.19%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.